Skip to main content
. 2021 Nov 10;13(Suppl 2):S1055–S1061. doi: 10.4103/jpbs.jpbs_165_21

Table 4a.

Ganglion cell layer-inner plexiform layer thickness in diabetic patients and control (n=180)

GCL-IPL thickness (µM) Diabetic eyes (n=120), mean (SD) Control eyes (n=60), mean (SD) P*

With retinopathy (n=60) Without retinopathy (n=60)
Superior 71.6 (3.0) 82.9 (2.3) 92.3 (2.2) <0.001
Superonasal 71.2 (2.8) 82.6 (2.2) 91.9 (2.5) <0.001
Superotemporal 71.7 (2.7) 82.6 (2.0) 92.5 (2.4) <0.001
Inferior 71.4 (3.0) 82.1 (2.5) 91.9 (2.7) <0.001
Inferonasal 71.9 (2.5) 83.2 (1.9) 91.9 (2.4) <0.001
Inferotemporal 71.5 (2.5) 82.5 (2.6) 92.6 (2.3) <0.001

*One way ANOVA. GCL-IPL: Ganglion cell layer-inner plexiform layer, SD: Standard deviation